ScripsAmerica's Pharmaceutical Equity Venture, Wholesale Rx, Continues Revenue Growth in February
March 24 2014 - 8:30AM
ScripsAmerica Inc. (OTCBB:SCRC), a leading
supplier of prescription, OTC and nutraceutical drugs, today
announced that the Company's equity venture, Wholesale Rx "WRx,"
received and processed $313,904 in orders during the month of
February. Since ScripsAmerica's formed this equity venture six
months ago, its monthly revenue has increased by 398%. WRx
experienced 17% growth over the past month which increased its run
rate from $3.2 to $3.8 million. February marked the third
consecutive month that WRx has broken its revenue record, marking
steady growth over the past quarter that began 2014. CEO of
ScripsAmerica, Bob Schneiderman, commented, "ScripsAmerica is now
experiencing growth in several areas of our business making this a
very exciting time for our shareholders. As the Company continues
to expand into new markets, having recently entered into a
management agreement with a compounding pharmacy and reported a
sizeable initial order for RapiMed in Hong Kong, WRx has
established itself as a pillar of ScripsAmerica's growth by
steadily increasing its monthly revenues." "The company expects to
obtain licensing that will allow WRx to distribute pharmaceuticals
in additional states in the coming months. This will expand our
market share in the pharmaceutical supply division of our business
which will continue to be a long-term source of revenue growth for
ScripsAmerica," continued Schneiderman.
About
ScripsAmerica, Inc. ScripsAmerica, Inc. is a supplier of
prescription, OTC and nutraceutical drugs, delivering
pharmaceutical products to a wide range of end users across the
health care industry. End users include retail pharmacies,
hospitals, long-term care facilities and government and home care
agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement This release includes
forward-looking statements, which are based on certain assumptions
and reflects management's current expectations. These
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results or events to differ
materially from current expectations. Some of these factors
include: general global economic conditions; general industry and
market conditions, sector changes and growth rates; uncertainty as
to whether our strategies and business plans will yield the
expected benefits; increasing competition; availability and cost of
capital; the ability to identify and develop and achieve commercial
success; the level of expenditures necessary to maintain and
improve the quality of services; changes in the economy; changes in
laws and regulations, including codes and standards, intellectual
property rights, and tax matters; or other matters not anticipated;
our ability to secure and maintain strategic relationships and
distribution agreements. The Company disclaims any intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
Contact: 888-959-7095
ir@sealpointconsulting.com
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Apr 2023 to Apr 2024